PATENT CLAIM ANALYSIS

Application Number: 16002865
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising a drug such as a triptan (e.g. rizatriptan) and/or an NSAID (e.g. meloxicam) in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability, solubility, or pharmacokinetics of the drug for the treatment of conditions such as pain.

Claim (Index 9):
The method of  claim 7 , wherein the dosage form contains about 100 mg to about 140 mg of the cyclodextrin.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.52273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15976800', '16001697', '15936176', '16000701', '15986215']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8260527720913137
- 35 USC 102 Novelty (BERT): 0.5847188221520195
- Combined Prediction Score: 0.8019193770973843
- Mean Citation Score: 436.63744
- Max Citation Score: 485.98398
- Similarity Product: 425.5833246278106

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test